A 410-patient JAMA trial found that the NAD supplement nicotinamide riboside did not slow early Parkinson’s. What patients and caregivers should know now.
Popular NAD Supplement Nicotinamide Riboside Failed to Slow Early Parkinson’s in a Year-Long Trial of 410 Patients
by | Oct 15, 2026 | Uncategorized | 0 comments
Recent Comments